vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and FREQUENCY ELECTRONICS INC (FEIM). Click either name above to swap in a different company.
AGIOS PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($20.0M vs $17.1M, roughly 1.2× FREQUENCY ELECTRONICS INC). FREQUENCY ELECTRONICS INC runs the higher net margin — 10.5% vs -541.1%, a 551.6% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs 8.3%). FREQUENCY ELECTRONICS INC produced more free cash flow last quarter ($-1.1M vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs 11.8%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Ultra Electronics Holdings is a British defence and security company. It was listed on the London Stock Exchange and was a constituent of the FTSE 250 Index until it was acquired by Cobham, which is itself owned by Advent International.
AGIO vs FEIM — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $17.1M |
| Net Profit | $-108.0M | $1.8M |
| Gross Margin | 90.6% | 38.2% |
| Operating Margin | -608.9% | 10.0% |
| Net Margin | -541.1% | 10.5% |
| Revenue YoY | 86.1% | 8.3% |
| Net Profit YoY | -11.9% | -32.1% |
| EPS (diluted) | $-1.86 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $17.1M | ||
| Q3 25 | $12.9M | $13.8M | ||
| Q2 25 | $12.5M | $20.0M | ||
| Q1 25 | $8.7M | $18.9M | ||
| Q4 24 | $10.7M | $15.8M | ||
| Q3 24 | $9.0M | $15.1M | ||
| Q2 24 | $8.6M | $15.6M | ||
| Q1 24 | $8.2M | $13.7M |
| Q4 25 | $-108.0M | $1.8M | ||
| Q3 25 | $-103.4M | $634.0K | ||
| Q2 25 | $-112.0M | $3.2M | ||
| Q1 25 | $-89.3M | $15.4M | ||
| Q4 24 | $-96.5M | $2.7M | ||
| Q3 24 | $947.9M | $2.4M | ||
| Q2 24 | $-96.1M | $2.6M | ||
| Q1 24 | $-81.5M | $130.0K |
| Q4 25 | 90.6% | 38.2% | ||
| Q3 25 | 87.0% | 36.8% | ||
| Q2 25 | 86.3% | 37.5% | ||
| Q1 25 | 87.6% | 43.8% | ||
| Q4 24 | 88.3% | 48.2% | ||
| Q3 24 | 91.3% | 44.4% | ||
| Q2 24 | 82.6% | 40.3% | ||
| Q1 24 | 92.3% | 22.6% |
| Q4 25 | -608.9% | 10.0% | ||
| Q3 25 | -907.4% | 2.6% | ||
| Q2 25 | -1020.1% | 16.4% | ||
| Q1 25 | -1222.0% | 18.3% | ||
| Q4 24 | -1165.3% | 16.5% | ||
| Q3 24 | -1146.9% | 15.7% | ||
| Q2 24 | -1228.3% | 16.0% | ||
| Q1 24 | -1124.3% | -3.4% |
| Q4 25 | -541.1% | 10.5% | ||
| Q3 25 | -803.1% | 4.6% | ||
| Q2 25 | -899.4% | 16.0% | ||
| Q1 25 | -1023.3% | 81.4% | ||
| Q4 24 | -899.6% | 16.8% | ||
| Q3 24 | 10574.7% | 16.1% | ||
| Q2 24 | -1115.7% | 16.9% | ||
| Q1 24 | -995.8% | 0.9% |
| Q4 25 | $-1.86 | $0.18 | ||
| Q3 25 | $-1.78 | $0.07 | ||
| Q2 25 | $-1.93 | $0.33 | ||
| Q1 25 | $-1.55 | $1.60 | ||
| Q4 24 | $-1.44 | $0.28 | ||
| Q3 24 | $16.22 | $0.25 | ||
| Q2 24 | $-1.69 | $0.28 | ||
| Q1 24 | $-1.45 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | $3.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $58.5M |
| Total Assets | $1.3B | $92.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | $3.0M | ||
| Q3 25 | $92.7M | $4.5M | ||
| Q2 25 | $80.9M | $4.7M | ||
| Q1 25 | $79.0M | $5.5M | ||
| Q4 24 | $76.2M | $9.7M | ||
| Q3 24 | $253.7M | $16.2M | ||
| Q2 24 | $84.5M | $18.3M | ||
| Q1 24 | $118.8M | $11.7M |
| Q4 25 | $1.2B | $58.5M | ||
| Q3 25 | $1.3B | $56.3M | ||
| Q2 25 | $1.4B | $55.6M | ||
| Q1 25 | $1.5B | $51.8M | ||
| Q4 24 | $1.5B | $36.2M | ||
| Q3 24 | $1.6B | $33.2M | ||
| Q2 24 | $660.5M | $39.8M | ||
| Q1 24 | $743.9M | $36.7M |
| Q4 25 | $1.3B | $92.3M | ||
| Q3 25 | $1.4B | $93.2M | ||
| Q2 25 | $1.5B | $93.7M | ||
| Q1 25 | $1.6B | $86.4M | ||
| Q4 24 | $1.7B | $77.8M | ||
| Q3 24 | $1.8B | $84.3M | ||
| Q2 24 | $773.1M | $83.3M | ||
| Q1 24 | $849.7M | $77.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $-523.0K |
| Free Cash FlowOCF − Capex | $-97.3M | $-1.1M |
| FCF MarginFCF / Revenue | -487.5% | -6.6% |
| Capex IntensityCapex / Revenue | 5.6% | 3.6% |
| Cash ConversionOCF / Net Profit | — | -0.29× |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | $-5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $-523.0K | ||
| Q3 25 | $-88.2M | $1.2M | ||
| Q2 25 | $-77.1M | $-155.0K | ||
| Q1 25 | $-111.5M | $-3.6M | ||
| Q4 24 | $-133.2M | $3.8M | ||
| Q3 24 | $-84.2M | $-1.5M | ||
| Q2 24 | $-72.6M | $7.5M | ||
| Q1 24 | $-99.9M | $4.2M |
| Q4 25 | $-97.3M | $-1.1M | ||
| Q3 25 | $-89.7M | $385.0K | ||
| Q2 25 | $-78.0M | $-786.0K | ||
| Q1 25 | $-112.3M | $-4.0M | ||
| Q4 24 | $-134.1M | $3.3M | ||
| Q3 24 | $-84.6M | $-1.8M | ||
| Q2 24 | $-72.7M | $6.7M | ||
| Q1 24 | $-100.0M | $3.9M |
| Q4 25 | -487.5% | -6.6% | ||
| Q3 25 | -696.5% | 2.8% | ||
| Q2 25 | -626.2% | -3.9% | ||
| Q1 25 | -1286.4% | -20.9% | ||
| Q4 24 | -1250.1% | 20.8% | ||
| Q3 24 | -944.2% | -11.8% | ||
| Q2 24 | -844.4% | 42.8% | ||
| Q1 24 | -1221.2% | 28.4% |
| Q4 25 | 5.6% | 3.6% | ||
| Q3 25 | 12.1% | 5.6% | ||
| Q2 25 | 7.0% | 3.2% | ||
| Q1 25 | 8.8% | 1.7% | ||
| Q4 24 | 9.0% | 3.3% | ||
| Q3 24 | 4.7% | 2.2% | ||
| Q2 24 | 1.8% | 5.3% | ||
| Q1 24 | 1.7% | 2.3% |
| Q4 25 | — | -0.29× | ||
| Q3 25 | — | 1.83× | ||
| Q2 25 | — | -0.05× | ||
| Q1 25 | — | -0.24× | ||
| Q4 24 | — | 1.44× | ||
| Q3 24 | -0.09× | -0.60× | ||
| Q2 24 | — | 2.85× | ||
| Q1 24 | — | 32.36× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGIO
Segment breakdown not available.
FEIM
| POC Revenue | $14.8M | 86% |
| POT Revenue | $2.3M | 13% |
